HCPLive Network

Smoke-Free Legislation Has Significant Health Benefits

TUESDAY, April 1, 2014 (HealthDay News) -- Introduction of smoke-free legislation is associated with reductions in preterm birth and hospital attendance for asthma, according to a review published online March 28 in The Lancet.

Jasper V. Been, PhD, from Maastricht University in the Netherlands, and colleagues conducted a systematic literature review to examine the impact of smoke-free legislation on perinatal and child health. Data were included from 11 studies involving more than 25 million births and 247,168 asthma exacerbations.

The researchers found that all studies used interrupted time-series designs, and they described local bans (five North American studies) and national bans (six European studies). One study had a high risk of bias, while six and four had moderate and low risk, respectively. There were correlations between smoke-free legislation and reductions in preterm birth (four studies, −10.4 percent; P = 0.016) and hospital attendances for asthma (three studies, −10.1 percent; P = 0.0001). There was no significant effect on low birth weight identified (six studies, −1.7 percent; P = 0.31).

"Smoke-free legislation is associated with substantial reductions in preterm births and hospital attendance for asthma," the authors write. "Together with the health benefits in adults, this study provides strong support for World Health Organization recommendations to create smoke-free environments."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.

Further Reading
Researchers have developed a math model that can accurately predict the progression from nephritis to interstitial fibrosis in patients with systemic lupus erythematosus.
Recent studies looking at neural response in patients with fibromyalgia have shown that people with this condition may have hypersensitivity to non-painful stimuli.
Adverse drug events involving psychiatric medications are not uncommon in emergency departments, according to a study published in JAMA Psychiatry.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) reported that proactive monitoring of dose adjustments of infliximab (IFX), one of the 4 anti-TNF-alpha proteins used to treat inflammatory diseases like Crohn’s disease (CD), ulcerative colitis (UC), and inflammatory bowel disease (IBD), could prolong the effectiveness of treatment.
The number of Americans dying from accidental overdoses of opioid analgesics jumped significantly from 1999 to 2011, according to a September data brief published by the US Centers for Disease Control and Prevention's National Center for Health Statistics.
About 14.5 million US cancer survivors are alive today, compared to just three million in 1971, the American Association for Cancer Research reported Tuesday.
The outbreak of the Ebola virus in West Africa is showing no signs of slowing down. As a result, President Barack Obama announced Tuesday that the United States would be getting even more directly involved in the effort to contain the outbreak and prevent it from spreading any further.
More Reading